Milestone reached in new leukemia drug
(Cold Spring Harbor Laboratory) Using a chemical compound called YKL-05-099, a team of cancer researchers from CSHL and the Dana Farber Institute was able to target the Salt-Inducible Kinase 3 (SIK3) pathway and extend survival in mice with MLL leukemia.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Cancer | Cancer & Oncology | Chemistry | International Medicine & Public Health | Laboratory Medicine | Leukemia | Sodium Chloride